Mizuho Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $250
Mizuho analyst Gregg Moskowitz maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Outperform and raises the price target from $240 to $250.
Read original at benzingaStocks · News reference
This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. Analysts have positive views on FTH stock.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 1:02 PM
- Checked
- Jul 28, 2026, 1:02 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
BMO Capital Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $235
BMO Capital analyst Keith Bachman maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Outperform and raises the price target from $186.25 to $235.
Read original at benzingaJefferies Maintains Buy on CrowdStrike Holdings, Raises Price Target to $240
Jefferies analyst Joseph Gallo maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $230 to $240.
Read original at benzingaBaird Maintains Neutral on CrowdStrike Holdings, Raises Price Target to $230
Baird analyst Shrenik Kothari maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Neutral and raises the price target from $220 to $230.
Read original at benzingaThis Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. AVGO receives Outperform rating with $455 PT.
Read original at benzingaNeedham Initiates Coverage On Faeth Therapeutics with Buy Rating, Announces Price Target of $56
Needham analyst Gil Blum initiates coverage on Faeth Therapeutics (NASDAQ:FTH) with a Buy rating and announces Price Target of $56.
Read original at benzinga